These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2894166)

  • 21. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
    Fiorentini C; Guillet C; Guazzi M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
    Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
    Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose and concentration-effect relations for rilmenidine.
    Dollery CT; Davies DS; Duchier J; Pannier B; Safar ME
    Am J Cardiol; 1988 Feb; 61(7):60D-66D. PubMed ID: 2894161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effort blood pressure control in the course of antihypertensive treatment.
    de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
    Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Scemama M; Février B; Beucler I; Dairou F
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
    Traub YM
    Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
    McInnes GT; O'Kane KP; Jonker J; Roth J
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S75-80. PubMed ID: 9331015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients.
    Trimarco B; Rosiello G; Sarno D; Lorino G; Rubattu S; DeLuca N; Volpe M
    Am J Cardiol; 1994 Dec; 74(13):36A-42A. PubMed ID: 7998584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and acceptability of rilmenidine in a population of 2 738 hypertensive diabetic patients].
    Kourilsky O; Meurin P
    Presse Med; 2002 Nov; 31(39 Pt 1):1864-8. PubMed ID: 12496718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmaco-epidemiologic evaluation of rilmenidine in 18,235 hypertensive patients].
    Luccioni R
    Presse Med; 1995 Dec; 24(38):1857-64. PubMed ID: 8545441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
    Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
    Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects.
    Finta E; Laude D; Alföldi S; Farsang C; Elghozi JL
    J Hypertens; 2006 Aug; 24(8):1619-25. PubMed ID: 16877965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of rilmenidine, a selective imidazoline I1 receptor binding ligand, in mild-to-moderate Thai hypertensive patients.
    Buranakitjaroen P; Kittipawong P; Koanantakul B; Piamsomboon C; Prasassarakich N; Silaraks S; Sukonthasarn A; Tiyapant A;
    J Med Assoc Thai; 2003 Oct; 86(10):903-10. PubMed ID: 14650701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Essential arterial hypertension treated with rilmenidin : what dose for what patient?].
    Amah G
    Presse Med; 1999 Jan; 28(1):11-6. PubMed ID: 9951504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.